GSBS Student Publications
Title
Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice
GSBS Program
Cancer Biology
Publication Date
2005-06-09
UMMS Affiliation
Department of Medicine, Division of Gastroenterology
Document Type
Article
Disciplines
Gastroenterology | Life Sciences | Medicine and Health Sciences
Abstract
BACKGROUND and AIMS: The impact of Helicobacter eradication therapy on the progression or regression of gastric lesions is poorly defined. This study examined the effects of eradication therapy on inflammation, atrophy, metaplasia, dysplasia, and cancer progression.
METHODS: C57BL/6 mice were infected with Helicobacter felis and received bacterial eradication therapy after 2, 6, or 12 months of infection. The gastric mucosa was examined at early, mid, and late intervals after eradication and graded for histology, expression pattern of alpha-catenin and beta-catenin, and IQGAP1.
RESULTS: Eradication of Helicobacter infection after 2 or 6 months of infection led to a regression of inflammation, restoration of parietal cell mass, and reestablishment of normal architecture. Progression to adenocarcinoma was prevented. Bacterial eradication at 1 year was associated with the reappearance of parietal cells, partial regression of inflammation, and restoration of architecture. Hyperplasia scores significantly improved, and dysplasia did not progress. Infected mice developed antral adenocarcinoma and gastric outlet obstruction by 24 months. Only 30% of the mice receiving bacterial eradication therapy at 12 months developed antral carcinoma. Bacterial eradication at any time during the first year of infection prevented death due to gastric outlet obstruction. The expression pattern of alpha-catenin, beta-catenin, and IQGAP1 varied with cell type and paralleled histologic changes.
CONCLUSIONS: Inflammation, metaplasia, and dysplasia are reversible with early eradication therapy; progression of dysplasia was arrested with eradication therapy given as late as 1 year and prevented gastric cancer-related deaths.
Source
Gastroenterology. 2005 Jun;128(7):1937-52.
Journal/Book/Conference Title
Gastroenterology
Related Resources
PubMed ID
15940628
Repository Citation
Cai, Xun; Carlson, Jane E.; Stoicov, Calin; Li, Hanchen; Wang, Timothy C.; and Houghton, JeanMarie, "Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice" (2005). GSBS Student Publications. 166.
https://escholarship.umassmed.edu/gsbs_sp/166